Data / Form D filings / TOTUSRX, INC.
TOTUSRX, INC.: Form D filings
TOTUSRX, INC., a pharmaceuticals company in Longmont, CO, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on November 29, 2018, reports $550,000 sold of a $2 million offering to 47 investors.
Find out what TOTUSRX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4051 CAMELOT CIRCLE, Longmont, CO, 80504
- Phone
- (303) 517-8981
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Colorado
- Year incorporated
- 2016
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1717735
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2018 | Amendment | $2,000,000 | $550,000 | $1,450,000 | 47 | Sep 10, 2017 | sec.gov |
| Sep 25, 2017 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| GEOFFREY THOMAS WILLIAMSON | Executive Officer | |
| CRAIG NORMAN CHANGSTROM | Executive Officer | |
| KEVIN MICHAEL CONLON | Executive Officer |
Every Form D from the week of Nov 26, 2018 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TOTUSRX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.